ArticleJournal of materials chemistry. C2026
Exploring the design space of SMART RHESINs as a modular nanocapsule platform for functional magnetic nanoparticles.
Article in Journal of materials chemistry. C, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Magnetic core/shell nanoparticles (CSNPs) are central to emerging imaging and theranostic concepts, yet translating different magnetic payloads into a common, chemically addressable and functionally expandable architecture remains challenging. SMART RHESIN nanocapsules encapsulate different magnetic nanoparticle (NP) systems within a protective phenolic resin shell and permit structural variation and post-synthetic functionalisation. Here we map the design space of SMART RHESIN phenolic resin hollow nanocapsules across 52 reactions varying monomer choice, CSNP type, loading, co-encapsulation, and polymer additives. The platform incorporates magnetic payloads ranging from lab-synthesised magnetite to commercial iron oxides and cubic NPs, while identifying biogenic magnetosomes as a boundary case for the present synthesis conditions, with the resulting nanocapsule diameter (about 100 to 400 nm) and shell thickness (about 10 to 80 nm) varying systematically with the choice of CSNP system and reaction conditions. Magnetic particle spectroscopy (MPS) indicates reduced viscosity-induced phase shifts for selected representative formulations from this expanded compositional set, phantom MPI demonstrates multi-colour imaging that resolves aqueous and immobilised SR29 signals within a single field of view, and surface carboxylates enable post-synthetic modification, illustrated by
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.